Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07348224 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine and Nicotine Analogues

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Interventions: Vaping of 6-methylnicotine (Other), Vaping of racemic nicotine (S-/R-nicotine) (Other), Vaping of synthetic S-nicotine (Other) to Vaping of 6-methylnicotine (Other), Vaping of racemic nicotine (S-/R-nicotine) (Other), Vaping of synthetic S-nicotine (Other)
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 14 of 23 entries
  2. Recruitment opened
    • Start date: Jul 13, 2026 to Aug 5, 2026
    • Site details revised
    v5
  3. Start date: Jul 2026 to Jul 13, 2026v4
  4. Start date: Jun 1, 2026 to Jul 2026
    • Secondary endpoints: 26 to 23
    v3
  5. Start date: Jan 31, 2026 to Jun 1, 2026v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Electronic cigarettes are battery-operated devices that can produce an aerosol by heating a liquid which commonly contains nicotine. In recent years, products containing synthetically produced nicotine and nicotine analogues have entered the market. However, it remains unclear whether these types of nicotine have the same effects as conventional nicotine derived from the tobacco plant. The aim of this study is to investigate the effects of these nicotine types and to gain a better understanding of their respective mechanisms of action.
Trial Details
NCT Number NCT07348224
Lead Sponsor Insel Gruppe AG, University Hospital Bern
Collaborators: Swiss Tobacco Prevention Funds
Conditions
(from sponsor)		 Nicotine, Vaping, Synthetic Nicotine, Nicotine Analogues
Related terms Vaping
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov